Dabur India Limited
Dabur is India’s leading FMCG, Ayurvedic and natural health care companies with wide network distribution across world.
Leading FMCG Company Dabur India Limited is the fourth largest FMCG Company in India and the world’s largest Ayurvedic and Natural Health Care Company with a portfolio of over 250 Herbal/Ayurvedic products.
Business segments
- Home & personal care (48.6%)
- Health care (31.4%)
- Food & Beverages (20%)
Top Brands
Dabur, Vatika, Real, Hajmola, Pudin Hara, Honitus, Lal Tail, Dabur Red, Dabur Amla, Dabur Chyawanprash and Dabur Honey etc.
Shareholding Pattern
-PUBLIC GROUP
-PROMOTER GROUP
Financial Summary
| Particulars | March 2022 | March 2023 | March 2024 |
| Sales | 10,889 | 11,530 | 12,404 |
| Sales Growth % | 13.88% | 5.89% | 7.58% |
| Expenses | 8,637 | 9,367 | 10,004 |
| Operating Profit | 2,252 | 2,162 | 2,400 |
| OPM % | 21% | 19% | 19% |
| Net Profit | 1,742 | 1,701 | 1,811 |
| EPS in Rs | 9.84 | 9.64 | 10.4 |
Synopsis of Financials
- Q3 FY25 consolidated revenue grew by 3.1% in INR terms and 5.6% in constant currency terms.
- Domestic business, including Badshah, grew by 1.7% with volume growth of approximately 1.5%.
- International business exhibited strong growth of 18.9% in constant currency terms.
Final Outlook
Revenue Performance: The company saw growth in Consumer Care and Food business segments, with year-over-year revenue increases.
Quarterly Variations: There is a noticeable drop in revenue between Q4 2023 and Q1 2024 for certain segments.
Asset Growth: The balance sheet indicates an increase in property and capital work-in-progress, signaling expansion.
During the quarter that concluded on December 31, Dabur India declared a net profit of Rs 522.38 crore. Compared to the net profit of Rs 514.22 crore recorded in the third quarter of the previous fiscal year, this represents an increase of about 2%.Dabur’s revenue of Rs 3,355.25 crore was 3% higher year-over-year than the Rs 3,255.06 crore it reported in the same quarter of FY24.Due to the delayed start of winters, which negatively impacted the winter care portfolio, Dabur India’s domestic business value and volumes climbed by just 1.7% and 1.2% on an annual basis, respectively. In Q3, the winter portfolio typically has a salience of 30 to 35 percent.
Dabur-India-Limited-PDF-Report